About KCI
A Spirit of Innovation
For more than 30 years, KCI has been at the forefront of advanced healing technologies that positively affect patients, families, caregivers and providers alike. KCI therapies, products and support are making a difference across all care settings in many countries around the globe. We design, manufacture, market and service a wide spectrum of innovative products that have been designed to improve clinical outcomes while helping to reduce the overall cost of care - all backed by a worldwide network of service and clinical support.
KCI continues to develop and look for new technologies and therapies to deliver advanced management of challenging clinical issues while helping to lower the cost of care. Our global commitment is focused on making a difference in the lives of patients both today and tomorrow.
The three primary KCI businesses include:
Advanced Wound Care - Includes the KCI Vacuum Assisted Closure, or V.A.C.® Therapy System, which has been clinically demonstrated to help promote wound healing through unique mechanisms of action while helping to reduce the overall cost of treating patients with complex wounds.
Regenerative Medicine - Represented by LifeCell® Corporation, a KCI company, and includes tissue-based products for use in reconstructive, orthopedic and urogynecologic surgical procedures to repair soft tissue defects.
Therapeutic Support Systems - Includes specialty hospital beds, mattress replacement systems and overlays designed to address pulmonary complications associated with immobility, to reduce skin breakdown and assist caregivers in the safe and dignified handling of patients of size.
The Company employs approximately 7,000 people and markets its products in more than 20 countries.